The Code Tray: The ACCP Emergency Medicine PRN Podcast
by Christian Kroll, PharmD, BCPS
Is this your podcast?Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Most discussed topics
Brands & references
Total monthly reach
Estimated from 2 chart positions in 2 markets.
By chart position
- 🇰🇪KE · Medicine#131500 to 3K
- 🇿🇦ZA · Medicine#163500 to 3K
- Per-Episode Audience
Est. listeners per new episode within ~30 days
300 to 1.8K🎙 Daily cadence·152 episodes·Last published 2d ago - Monthly Reach
Unique listeners across all episodes (30 days)
1K to 6K🇰🇪50%🇿🇦50% - Active Followers
Loyal subscribers who consistently listen
400 to 2.4K
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
From 17 epsHosts
Recent guests
Recent episodes
Intramuscular Droperidol, Olanzapine, Midazolam, or Lorazepam for Meth Intoxication in the ED
Jun 23, 2026
Unknown duration
Recombinant Factor VIIa vs Placebo for Spontaneous ICH Within 2 Hours of Onset: The FASTEST Trial
Jun 16, 2026
Unknown duration
Navigating the Pharmacologic Terrain in Pseudo-Pulseless Electrical Activity
Jun 9, 2026
15m 24s
Succinylcholine vs Rocuronium for Pediatric Rapid Sequence Intubation in the Emergency Department
Jun 2, 2026
15m 51s
IV Thrombolysis in Patients With Ischemic Stroke and Recent Ingestion of Direct Oral Anticoagulants
May 26, 2026
22m 04s
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Topics | Guests | Brands | Places | Keywords | Sponsor | Length | |
|---|---|---|---|---|---|---|---|---|---|
| 6/23/26 | Intramuscular Droperidol, Olanzapine, Midazolam, or Lorazepam for Meth Intoxication in the ED | ACCP EM PRN: June 2026Article: https://www.sciencedirect.com/science/article/abs/pii/S0735675726000999Presenter: Rebecca Lally, PharmD | Incoming PGY-1 Resident | Brigham and Women’s HospitalCopyright Notice: By accessing this podcast, you understand and acknowledge that its contents and materials are the property of ACCP and the Emergency Medicine PRN. Further, the podcast, its contents and its materials are protected under United States and international copyright and trademark law. You understand that the podcast, its contents or materials are to be used only for personal or non-commercial purposes.Limitation of Liability; ACCP AND THE EMERGENCY MEDICINE PRN DISCLAIM ANY AND ALL LIABILITY OR RESPONSIBILITY FOR ANY DIRECT, INDIRECT, INCIDENTAL, SPECIAL, CONSEQUENTIAL, OR ANY OTHER DAMAGES, INCLUDING WITHOUT LIMITATION, LOSS OF PROFITS, ARISING OUT OF ANY USE OF, REFERENCE TO, RELIANCE ON, OR INABILITY TO USE THE PODCAST, ITS CONTENTS AND MATERIALS.Produced by Christian Kroll, PharmD, BCPS | — | ||||||
| 6/16/26 | Recombinant Factor VIIa vs Placebo for Spontaneous ICH Within 2 Hours of Onset: The FASTEST Trial | ACCP EM PRN: June 2026Article: https://pubmed.ncbi.nlm.nih.gov/41653933/Presenter: Madelyn Johnson, PharmD, MBA | PGY2 Emergency Medicine Pharmacy Resident | Mayo ClinicCopyright Notice: By accessing this podcast, you understand and acknowledge that its contents and materials are the property of ACCP and the Emergency Medicine PRN. Further, the podcast, its contents and its materials are protected under United States and international copyright and trademark law. You understand that the podcast, its contents or materials are to be used only for personal or non-commercial purposes.Limitation of Liability; ACCP AND THE EMERGENCY MEDICINE PRN DISCLAIM ANY AND ALL LIABILITY OR RESPONSIBILITY FOR ANY DIRECT, INDIRECT, INCIDENTAL, SPECIAL, CONSEQUENTIAL, OR ANY OTHER DAMAGES, INCLUDING WITHOUT LIMITATION, LOSS OF PROFITS, ARISING OUT OF ANY USE OF, REFERENCE TO, RELIANCE ON, OR INABILITY TO USE THE PODCAST, ITS CONTENTS AND MATERIALS.Produced by Christian Kroll, PharmD, BCPS | — | ||||||
| 6/9/26 | Navigating the Pharmacologic Terrain in Pseudo-Pulseless Electrical Activity✨ | pharmacologyemergency medicine+3 | Kevin Mercer, PharmD, MPH, FCCMKevin Mercer | The University of Texas at Austin, College of PharmacyACCP+1 | — | pharmacologypseudo-pulseless electrical activity+3 | — | 15m 24s | |
| 6/2/26 | Succinylcholine vs Rocuronium for Pediatric Rapid Sequence Intubation in the Emergency Department✨ | pediatric emergency medicinerapid sequence intubation+3 | Sarah Markovich, PharmDSarah Markovich | Penn Presbyterian Medical CenterACCP+2 | — | succinylcholinerocuronium+4 | — | 15m 51s | |
| 5/26/26 | IV Thrombolysis in Patients With Ischemic Stroke and Recent Ingestion of Direct Oral Anticoagulants✨ | thrombolysisischemic stroke+3 | Parker Quinlan, PharmDParker Quinlan | Rush University System for HealthACCP+2 | — | thrombolysisischemic stroke+3 | — | 22m 04s | |
| 5/19/26 | Fewer Admissions, Shorter Stays: Phenobarbital Use for Alcohol Withdrawal in the ED✨ | alcohol withdrawalemergency medicine+3 | Maddie (Lee) Barrett | University of Kentucky HealthCareACCP+1 | — | phenobarbitalalcohol withdrawal+3 | — | 25m 50s | |
| 5/12/26 | Bleeding Risk with Apixaban vs. Rivaroxaban in Acute Venous Thromboembolism: The COBRRA Trial✨ | bleeding riskapixaban+4 | Emma Seals | ApixabanRivaroxaban+3 | — | bleeding riskApixaban+5 | — | 22m 30s | |
| 5/5/26 | Emergency Department-Initiated Buprenorphine for Opioid Use Disorder✨ | Opioid Use DisorderEmergency Medicine+3 | Morgan Hayslip, PharmDMorgan Hayslip | ACCPEmergency Medicine PRN | MercyOne Des Moines Medical Center | buprenorphineopioid use disorder+3 | — | 21m 30s | |
| 4/28/26 | The HOPE Randomized Clinical Trial: Alteplase for Acute Ischemic Stroke at 4.5 to 24 Hours✨ | acute ischemic strokeclinical trial+3 | Julien Trujillo | The Ohio State University College of PharmacyACCP+1 | — | HOPE trialalteplase+4 | — | 19m 33s | |
| 4/21/26 | Timing of Initiation and Efficacy of Dual Antiplatelet Therapy in Minor Stroke or High-Risk TIA✨ | Dual Antiplatelet TherapyMinor Stroke+3 | Dan Smith, PharmD | NewYork-Presbyterian HospitalACCP+1 | — | antiplatelet therapyminor stroke+3 | — | 22m 02s | |
Want analysis for the episodes below?Free for Pro Submit a request, we'll have your selected episodes analyzed within an hour. Free, at no cost to you, for Pro users. | |||||||||
| 4/14/26 | Time to Vasopressor Initiation Is Not Associated With Increased Mortality in Septic Shock✨ | septic shockvasopressors+3 | Zackary Austin | University of Kentucky College of PharmacyACCP+1 | — | vasopressorseptic shock+3 | — | 20m 08s | |
| 4/7/26 | Ticagrelor and Aspirin or Aspirin Alone after Coronary Surgery for ACS: The TACSI Trial✨ | Coronary SurgeryACS+3 | Lindsey Clemmons, PharmD | TicagrelorAspirin+3 | — | TicagrelorAspirin+5 | — | 17m 03s | |
| 3/31/26 | Early Intensive Blood Pressure Reduction After ICH Is Associated With Worse Functional Outcome✨ | blood pressure reductionintracerebral hemorrhage+3 | Michelle Galvez, PharmD | University of Kentucky HealthcareACCP+1 | — | blood pressureintracerebral hemorrhage+3 | — | 30m 52s | |
| 3/24/26 | Haloperidol vs Ketamine for Management in Acute Agitation in the ED: A Randomized Clinical Trial✨ | acute agitationemergency medicine+4 | Joe Champoux, PharmD, MBAJoe Champoux | ACCPEmergency Medicine PRN+1 | DMC – Detroit Receiving Hospital | haloperidolketamine+4 | — | 16m 00s | |
| 3/17/26 | Evaluation of Patient Outcomes Associated With LR vs Normal Saline in Patients Presenting with DKA✨ | patient outcomesDKA+3 | Torrie Smith, PharmD | OhioHealth Marion General HospitalACCP+1 | — | patient outcomesLactated Ringer's+5 | — | 15m 31s | |
| 3/10/26 | Hyperkalemic Emergency Department Patients Intubated with Rocuronium or Succinylcholine✨ | hyperkalemiaemergency medicine+3 | Zack Moreo, PharmD | Grady Health SystemACCP+2 | — | hyperkalemiaintubation+5 | — | 14m 41s | |
| 3/3/26 | Adjunctive Terlipressin versus Placebo in the Treatment of Refractory Septic Shock✨ | septic shockterlipressin+3 | Sharon Gip | ACCPEmergency Medicine PRN+1 | Scripps Mercy San Diego Hospital | terlipressinseptic shock+3 | — | 14m 38s | |
| 2/24/26 | Levetiracetam Dosing Optimization in Neurocritical Care Population: Neuro-ARC Study✨ | levetiracetamdosing optimization+3 | Kylie Wong, PharmD | ACCPUW Health+1 | United States | levetiracetamdosing optimization+5 | — | 18m 13s | |
| 2/17/26 | Landiolol for Refractory Ventricular Fibrillation in Out-of-Hospital Cardiac Arrest✨ | emergency medicinecardiac arrest+3 | Megan Szesnat | ACCPEmergency Medicine PRN+2 | United States | Landiololventricular fibrillation+5 | — | 27m 02s | |
| 2/10/26 | Vernakalant vs Procainamide for Rapid Cardioversion of Patients with Acute Afib: The RAFF4 Trial | ACCP EM PRN: January 2026Article: https://pubmed.ncbi.nlm.nih.gov/41218981/Presenter: Tom Szwajnos, PharmD | PGY2 Emergency Medicine Pharmacy Resident | Advocate Christ Medical CenterCopyright Notice: By accessing this podcast, you understand and acknowledge that its contents and materials are the property of ACCP and the Emergency Medicine PRN. Further, the podcast, its contents and its materials are protected under United States and international copyright and trademark law. You understand that the podcast, its contents or materials are to be used only for personal or non-commercial purposes.Limitation of Liability; ACCP AND THE EMERGENCY MEDICINE PRN DISCLAIM ANY AND ALL LIABILITY OR RESPONSIBILITY FOR ANY DIRECT, INDIRECT, INCIDENTAL, SPECIAL, CONSEQUENTIAL, OR ANY OTHER DAMAGES, INCLUDING WITHOUT LIMITATION, LOSS OF PROFITS, ARISING OUT OF ANY USE OF, REFERENCE TO, RELIANCE ON, OR INABILITY TO USE THE PODCAST, ITS CONTENTS AND MATERIALS.Produced by Christian Kroll, PharmD, BCPS | — | ||||||
| 2/3/26 | Optimal Vasopressin Initiation in Septic Shock: The OVISS Reinforcement Learning Study | ACCP EM PRN: January 2026Article: https://pubmed.ncbi.nlm.nih.gov/40098600/Presenter: Landry Slaughter, PharmD, MMHC | PGY2 Critical Care Pharmacy Resident | Vanderbilt University Medical CenterCopyright Notice: By accessing this podcast, you understand and acknowledge that its contents and materials are the property of ACCP and the Emergency Medicine PRN. Further, the podcast, its contents and its materials are protected under United States and international copyright and trademark law. You understand that the podcast, its contents or materials are to be used only for personal or non-commercial purposes.Limitation of Liability; ACCP AND THE EMERGENCY MEDICINE PRN DISCLAIM ANY AND ALL LIABILITY OR RESPONSIBILITY FOR ANY DIRECT, INDIRECT, INCIDENTAL, SPECIAL, CONSEQUENTIAL, OR ANY OTHER DAMAGES, INCLUDING WITHOUT LIMITATION, LOSS OF PROFITS, ARISING OUT OF ANY USE OF, REFERENCE TO, RELIANCE ON, OR INABILITY TO USE THE PODCAST, ITS CONTENTS AND MATERIALS.Produced by Christian Kroll, PharmD, BCPS | — | ||||||
| 1/27/26 | Ketamine or Etomidate for Tracheal Intubation of Critically Ill Adults | ACCP EM PRN: January 2026Article: https://pubmed.ncbi.nlm.nih.gov/41369227/Presenter: Zoe Dittmar, PharmD | PGY2 Emergency Medicine Pharmacy Resident | Iowa Health CareCopyright Notice: By accessing this podcast, you understand and acknowledge that its contents and materials are the property of ACCP and the Emergency Medicine PRN. Further, the podcast, its contents and its materials are protected under United States and international copyright and trademark law. You understand that the podcast, its contents or materials are to be used only for personal or non-commercial purposes.Limitation of Liability; ACCP AND THE EMERGENCY MEDICINE PRN DISCLAIM ANY AND ALL LIABILITY OR RESPONSIBILITY FOR ANY DIRECT, INDIRECT, INCIDENTAL, SPECIAL, CONSEQUENTIAL, OR ANY OTHER DAMAGES, INCLUDING WITHOUT LIMITATION, LOSS OF PROFITS, ARISING OUT OF ANY USE OF, REFERENCE TO, RELIANCE ON, OR INABILITY TO USE THE PODCAST, ITS CONTENTS AND MATERIALS.Produced by Christian Kroll, PharmD, BCPS | — | ||||||
| 1/20/26 | Reaction Control: Does Epinephrine Dose Make a Difference? | ACCP EM PRN: December 2025Article: https://doi.org/10.1016/j.ajem.2025.10.020Presenter: Hannah Moore, PharmD | PGY2 Emergency Medicine Pharmacy Resident | UofL Health Copyright Notice: By accessing this podcast, you understand and acknowledge that its contents and materials are the property of ACCP and the Emergency Medicine PRN. Further, the podcast, its contents and its materials are protected under United States and international copyright and trademark law. You understand that the podcast, its contents or materials are to be used only for personal or non-commercial purposes.Limitation of Liability; ACCP AND THE EMERGENCY MEDICINE PRN DISCLAIM ANY AND ALL LIABILITY OR RESPONSIBILITY FOR ANY DIRECT, INDIRECT, INCIDENTAL, SPECIAL, CONSEQUENTIAL, OR ANY OTHER DAMAGES, INCLUDING WITHOUT LIMITATION, LOSS OF PROFITS, ARISING OUT OF ANY USE OF, REFERENCE TO, RELIANCE ON, OR INABILITY TO USE THE PODCAST, ITS CONTENTS AND MATERIALS.Produced by Christian Kroll, PharmD, BCPS | — | ||||||
| 1/13/26 | Evaluation of Diltiazem Dosing Strategies in the Management of Atrial Fibrillation in the ED | ACCP EM PRN: December 2025Article: https://pubmed.ncbi.nlm.nih.gov/41237672/Presenter: Ryan Bloesser, PharmD | PGY2 Critical Care Pharmacy Resident | University HealthCopyright Notice: By accessing this podcast, you understand and acknowledge that its contents and materials are the property of ACCP and the Emergency Medicine PRN. Further, the podcast, its contents and its materials are protected under United States and international copyright and trademark law. You understand that the podcast, its contents or materials are to be used only for personal or non-commercial purposes.Limitation of Liability; ACCP AND THE EMERGENCY MEDICINE PRN DISCLAIM ANY AND ALL LIABILITY OR RESPONSIBILITY FOR ANY DIRECT, INDIRECT, INCIDENTAL, SPECIAL, CONSEQUENTIAL, OR ANY OTHER DAMAGES, INCLUDING WITHOUT LIMITATION, LOSS OF PROFITS, ARISING OUT OF ANY USE OF, REFERENCE TO, RELIANCE ON, OR INABILITY TO USE THE PODCAST, ITS CONTENTS AND MATERIALS.Produced by Christian Kroll, PharmD, BCPS | — | ||||||
| 1/6/26 | Efficacy and Safety of Ketamine or Ketorolac Compared to Opioids in Painful Vaso-Occlusive Crisis | ACCP EM PRN: December 2025Article: https://pubmed.ncbi.nlm.nih.gov/41185920/Presenter: Magda Jasinska, PharmD | PGY2 Critical Care Pharmacy Resident | UNC Health Rex Copyright Notice: By accessing this podcast, you understand and acknowledge that its contents and materials are the property of ACCP and the Emergency Medicine PRN. Further, the podcast, its contents and its materials are protected under United States and international copyright and trademark law. You understand that the podcast, its contents or materials are to be used only for personal or non-commercial purposes.Limitation of Liability; ACCP AND THE EMERGENCY MEDICINE PRN DISCLAIM ANY AND ALL LIABILITY OR RESPONSIBILITY FOR ANY DIRECT, INDIRECT, INCIDENTAL, SPECIAL, CONSEQUENTIAL, OR ANY OTHER DAMAGES, INCLUDING WITHOUT LIMITATION, LOSS OF PROFITS, ARISING OUT OF ANY USE OF, REFERENCE TO, RELIANCE ON, OR INABILITY TO USE THE PODCAST, ITS CONTENTS AND MATERIALS.Produced by Christian Kroll, PharmD, BCPS | — | ||||||
Showing 25 of 162
Pitch Fit is a Pro feature
See how bookable this show is for guests, which brands already advertise, the per-episode ad value, and the best-fit guest and sponsor profile. The numbers are blurred on the free plan.
How readily this show books outside guests like you.
How proven this show is for host-read sponsorships.
For Guests
ProFor Advertisers
ProUpgrade to Pro to unlock guest cadence, sponsor categories, fit scores, and per-episode ad value for this show.
Chart Positions
2 placements across 2 markets.
Chart Positions
2 placements across 2 markets.